Biosynex SA (FR:ALBIO) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Biosynex SA, a leader in health diagnostics, reported a turnover of €93 million in 2023 and has expanded its international presence with subsidiaries in the US, Europe, and Asia. Specializing in rapid tests and molecular biology, the company offers a range of diagnostic and care solutions for both professionals and the general public. With over 500 employees and operations in 95 countries, Biosynex is listed on Euronext Growth Paris and continues to innovate in the field of rapid diagnostics.
For further insights into FR:ALBIO stock, check out TipRanks’ Stock Analysis page.